Fujiwara Toshihiko | R&D Planning Department, R&D Division, Daiichi Sankyo Co., Ltd., Japan
スポンサーリンク
概要
関連著者
-
Takahashi Kanako
Cardiovascular Medicine, Kyoto University
-
Okuno Akira
Cardiovascular-Metabolics Research Laboratories, R&D Division, Daiichi Sankyo Co., Ltd., Japan
-
Hagisawa Yuka
Cardiovascular-Metabolics Research Laboratories, R&D Division, Daiichi Sankyo Co., Ltd., Japan
-
Fujiwara Toshihiko
R&D Planning Department, R&D Division, Daiichi Sankyo Co., Ltd., Japan
-
Ogawa Junko
Cardiovascular-metabolics Res. Laboratories R&d Div. Daiichi Sankyo Co. Ltd. Jpn
-
Kanda Shoichi
Cardiovascular-metabolics Res. Laboratories R&d Div. Daiichi Sankyo Co. Ltd. Jpn
-
Yoshida Taishi
Cardiovascular-metabolics Research Laboratories R&d Division Daiichi Sankyo Co. Ltd.
-
Okuno Akira
Cardiovascular-metabolics Research Laboratories R&d Division Daiichi Sankyo Co. Ltd.
-
Takahashi Kanako
Cardiovascular-metabolics Research Laboratories R&d Division Daiichi Sankyo Co. Ltd.
-
Hagisawa Yuka
Cardiovascular-metabolics Research Laboratories R&d Division Daiichi Sankyo Co. Ltd.
-
Yoshida Taishi
Cardiovascular-Metabolics Research Laboratories, R&D Division, Daiichi Sankyo Co., Ltd., Japan
-
Ogawa Junko
Cardiovascular-Metabolics Research Laboratories, R&D Division, Daiichi Sankyo Co., Ltd., Japan
-
Kanda Shoichi
Cardiovascular-Metabolics Research Laboratories, R&D Division, Daiichi Sankyo Co., Ltd., Japan
-
Kanda Shoichi
Biological Research Laboratories Ii Daiichi Sankyo Co. Ltd.
-
Fujiwara Toshihiko
R&d Planning Department R&d Division Daiichi Sankyo Co. Ltd.
著作論文
- Contributions of Hepatic Gluconeogenesis Suppression and Compensative Glycogenolysis on the Glucose-Lowering Effect of CS-917, a Fructose 1,6-Bisphosphatase Inhibitor, in Non-obese Type 2 Diabetes Goto-Kakizaki Rats
- Contributions of Hepatic Gluconeogenesis Suppression and Compensative Glycogenolysis on the Glucose-Lowering Effect of CS-917, a Fructose 1,6-Bisphosphatase Inhibitor, in Non-obese Type 2 Diabetes Goto-Kakizaki Rats